Dermatology.Business | Chronicle Companies | Substack

Now that Apotex bought Blexten-maker Searchlight, could other derm acquisitions follow?

The Canadian generic mainstay positions itself for international growth in branded Rxs. Which takeover target will be next? Plus: red-hot laser market, CMO merger, tired Pso patients, and much more

READ THE LATEST

Most Popular

When did every dermatologist suddenly become a rock star?

Dec 4, 2024 • Chronicle Companies

L'Oréal takes 10% stake in Galderma, forms R&D partnership

Aug 14, 2024 • Chronicle Companies

Aesthetic chain's collapse sends shockwaves through UK cosmetic medicine clinics

Jul 31, 2024 • Chronicle Companies

Investors taking notice: Dermatology market booming (despite threats)

Aug 28, 2024 • Chronicle Companies

Dermatology.Business

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts